Announced Mon, 13 Apr · 17:35 IST
Brawn Biotech declares non-applicability of Large Corporate norms
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.5%1-day move
₹20.48
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.5——+9.4+12.1—+0.1+5.5-4.8-2.3
Up moveDown movePending
AI summary
Brawn Biotech Ltd has filed an initial disclosure confirming it does not qualify as a 'Large Corporate' under SEBI's November 2018 framework on debt securities. The company reported NIL outstanding borrowings as of 31st March 2025, and credit rating is not applicable. This is a routine annual compliance filing required of all listed entities.
Likely market impact
Routine compliance filing with no material impact on shareholders; company carries no outstanding debt as of March 2025.